Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Population Science
Risk Factors That Most Accurately Predict Coronary Artery Disease Based on the Duration of Follow-up ― NIPPON DATA80 ―
Yukiko OkamiHirotsugu UeshimaYasuyuki NakamuraKeiko KondoAya KadotaNagako OkudaTakayoshi OhkuboNaomi MiyamatsuTomonori OkamuraKatsuyuki MiuraAkira Okayamafor the NIPPON DATA80 Research Group
Author information
JOURNAL OPEN ACCESS FULL-TEXT HTML
Supplementary material

2021 Volume 85 Issue 6 Pages 908-913

Details
Abstract

Background:This study assessed sex-specific time-associated changes in the impact of risk factors on coronary artery disease (CAD) mortality in a general population over long-term follow-up.

Methods and Results:A prospective longitudinal cohort study was conducted on representative Japanese populations followed up for 29 years. Data from 8,396 participants (3,745 men, 4,651 women) were analyzed. The sex-specific multivariable adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) of 4 risk factors (smoking, diabetes, serum total cholesterol [TC], and systolic blood pressure [SBP]) for CAD mortality were calculated at baseline and at 10, 15, 20, 25, and 29 years of follow-up. In men, smoking (HR 3.23; 95% CI 1.16–9.02) and a 1-SD increase in TC (HR 1.82; 95% CI 1.29–2.57) were strongly associated with a higher risk of CAD in the first 10 years, but this association decreased over time. Diabetes (HR 2.30; 95% CI 1.37–3.85) and a 1-SD increase in SBP (HR 1.23; 95% CI 1.00–1.50) were strongly correlated with a higher risk of CAD after 29 years). In women, diabetes was correlated with CAD after 20 years (HR 2.53; 95% CI 1.19–5.36) and this correlation persisted until after 29 years (HR 2.47; 95% CI 1.40–4.35).

Conclusions:The duration of follow-up needed for the accurate assessment of risk factors for CAD mortality varies according to risk factor and sex.

Content from these authors
© 2021, THE JAPANESE CIRCULATION SOCIETY

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Previous article Next article
feedback
Top